Skip to main content

Webinar: Rapid response, low-cost manufacturing of viral vaccines against emerging infectious disease threats РBatavia

June 29, 2023

June 29th

Time 11 AM to 12 noon(CET) 

Vaccine inequality & low public acceptance inhibit vaccine uptake and limit coverage. Approximately 25m children under 1 year of age did not receive basic vaccines (highest since 2009). Global vaccine coverage dropped during COVID pandemic to 81%, and only 29% of the population in developing countries was vaccinated against Covid. Our HIP-Vax platform can help solve these issues by shortening the time to the clinic and greatly reducing vaccine manufacturing costs. Our HIP-Vax platform helps make vaccines more affordable and allows for more equitable access.

Speaker Name 

Alfred Luitjens – Global Technical Sales Director – Batavia Biosciences 


Alfred Luitjens is Global Technical Sales Director at Batavia Biosciences. He has a profound background in the development and production of vaccines, with more than 30 years of experience. He worked for research & development at Solvay, DSM Biologics and Crucell. He had a management position at the Animal Science Group and was a Senior Manager of Process Architecture at GSK. At Batavia Biosciences, Alfred is responsible for writing all project proposals and key account management, advising organizations worldwide on vaccine development.

One Pager Report - Batavia Biosciences